FOXM1 and acute lymphoblastic leukemia: Buchner reported that FOXM1 inhibition exhibited a cytotoxic effect on B cells without any effect on normal B cell development and survival and suggested FOXM1 as a therapeutic target for acute lymphoblastic leukemia (59).